Rare Disease Leaders Call for Regulatory Clarity as FDA Balances Urgency with Rigor
With CBER director Vinay Prasad set to depart the agency at the end of the month, a coalition of patient ...
Read moreDetails
Tag: FDA
Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation
Complement Therapeutics has announced that CTx001, its gene therapy for geographic atrophy (GA) secondary to age-related macular degeneration (AMD), has ...
Read moreDetails
New drug to slow down Alzheimer’s disease
The FDA recently granted accelerated approval for a new drug, Lecanemab, which is designed to slow the progression of Alzheimer's ...
Read moreDetails
